Clearview Cancer Center

Quick Links:

Clearview News Wire

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.



Family history not the sole risk for breast cancer

Last Updated: 2010-12-30 15:07:15 -0400 (Reuters Health)

January 3, 2011

By Lynne Peeples

NEW YORK (Reuters Health) - A new study reconfirms something often forgotten by women and sometimes even by doctors: just because breast cancer has not struck a family before does not mean family members are safe from the disease.

Researchers tracking more than 6,000 women for up to six years found that most cases of breast cancer occurred in those without a family history of the disease, although many of the women had other known risk factors that can help predict an individual woman's likelihood of developing the disease.

Breast cancer accounts for about a quarter of all cancers in women, with nearly 200,000 new cases of invasive breast cancer -- disease that has spread beyond the milk ducts or milk-making glands -- diagnosed in the U.S. every year.

"I have newly-diagnosed breast cancer patients ask me all the time how they could have developed the disease since they did not have a family history," researcher Dr. Lawrence Wickerham of the National Surgical Adjuvant Breast and Bowel Project (NSABP) Allegheny Center, in Pittsburgh, told Reuters Health in an e-mail.

Prior studies have shown that more than 70 percent of primary care doctors ask women about their family histories, while less than half collect information on other known risk factors such as whether a woman's period began before age 12 - which raises risk - or whether she has given birth, which lowers risk.

Wickerham, along with lead researcher Angelina Sontag, of Eli Lilly and Company, and their colleagues analyzed the roles of various risk factors among 6,322 postmenopausal women who had participated in two large trials of osteoporosis medications. (Eli Lilly and Company, a maker of breast cancer treatments, also funded the current study.)

At the time of each trial, all of the women were under 86 years old and none had received a previous diagnosis of breast cancer.

The team used the Breast Cancer Risk Assessment Tool (http://www.cancer.gov/bcrisktool), an online questionnaire developed by NSABP and the National Cancer Institute, to go back in time and predict the odds that the women would develop invasive disease over the next five years.

The risk calculator incorporates age of first menstruation, current age, ethnicity, reproductive history, prior breast biopsies and family history. Its score, on a scale of zero to eight, represents a woman's five-year risk as a percentage.

Some 600 women in the study group -- approximately one in ten -- had a family history of breast cancer and nearly all of these met the predictive tool's definition of high risk: a score of 1.66 percent or above.

More than half of the remaining women without family histories of breast cancer also fit into the high-risk category, however.

A total of 92 women, or 1.5 percent of the study population, went on to develop invasive breast cancer over an average follow-up period of 4 to 6 years. As expected, the actual rate of breast cancers increased with the predicted risks, as well as in the presence of a family history.

Nevertheless, more of the total number of breast cancer cases ended up being reported in women with predictions below the high-risk cut-off or without a family history.

Close to half (40) of the women who developed the disease received a risk score below 1.66 percent, for example, and nearly two of every three (60) diagnosed women had been assigned risks between 1 and 2 percent and had no family history of breast cancer.

"The single largest risk factor for developing a breast cancer is being a woman and the second largest is being a women over 50," said Wickerham. "However, there are some women who are at greater than average risk, particularly those with a family history."

The most common known risk factors found in the study population were being at least 65 years old and beginning menstruation before the age of 12, report the researchers in the journal Menopause.

"Physicians and other health care providers should consider using methods beyond asking about family history to access breast cancer risk," added Wickerham, alluding to the Breast Cancer Risk Assessment Tool. "Such efforts can help better identify women at increased risk and can better focus screening and prevention strategies for them."

SOURCE: http://link.reuters.com/cuf34r Menopause, online December 25, 2010.

Other Articles:

May 15, 2013
Actress has double mastectomy to elude breast cancer
May 15, 2013
FDA strengthens warnings on tanning beds
April 30, 2013
Supplements don't help with prostate cancer: study
April 25, 2013
New York City aims to ban cigarette sales under 21s
April 4, 2013
Smokers have worse colon cancer prognosis
April 3, 2013
Counsel women with likely BRCA family history
March 28, 2013
Soy tied to better lung cancer survival among women.
March 25, 2013
Help with end-of-life talks
March 22, 2013
Immune-system therapy shows promise in adults with leukemia
March 21, 2013
Umbrellas may shield you from more than rain: study
March 20, 2013
Less frequent mammograms OK after 50: study
March 12, 2013
Fight tobacco, use vaccines to curb cancer: report
February 20, 2013
TV's Robin Roberts returns to 'Good Morning America'
February 14, 2013
PSA decision tools may help men clarify their values
February 8, 2013
Longer span between mammograms okay for older women
January 31, 2013
Study supports lumpectomy in early breast cancer
January 28, 2013
High doses of folic acid not tied to cancer risk
January 24, 2013
Exercise tied to better colon cancer survival odds
January 16, 2013
UK cost agency backs drugs for breast cancer
January 11, 2013
Pap test fluid may be used to cancers: study
January 10, 2013
Pap test fluid may be used to cancers: study
January 8, 2013
Medicare spends $1 billion on mammograms: study
January 7, 2013
In war on cancer, progress is in eye of the beholder
January 3, 2013
Surgery not helpful in metastatic neuroblastoma
December 19, 2012
Do UK guidelines catch more colon polyps than US?
December 19, 2012
9/11 responders may have higher risk of some cancers
December 17, 2012
Men more likely to die of cancer: study
December 17, 2012
CORRECTION: Aspirin may help older colon cancer patients live longer
December 13, 2012
California governor treated for prostate cancer
View All Cancer News